Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 37.74 | 50.67 |
PEG Ratio (TTM) | -2.77 | -8.93 |
P/S Ratio (TTM) | 2.40 | 14.09 |
P/B Ratio (TTM) | 4.07 | 12.78 |
P/FCF Ratio (TTM) | 22.94 | 45.71 |
Price to 5YR AVG Earnings Ratio | N/A | 70.15 |
Price to 5YR AVG FCF Ratio | N/A | 75.18 |
Profitability (35%) |
Company | Industry |
---|---|---|
ROA (TTM) | 5.14% | -2.58% |
ROE (TTM) | 8.37% | 6.65% |
Net Profit Margin (TTM) | 6.54% | 3.92% |
ROIC 5YR AVG | N/A | 4.82% |
Growth (22%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -11.84% | -39.20% | N/A |
Revenue | 2.54% | 24.04% | N/A |
Net Income | -11.49% | -41.40% | N/A |
Cash Flow | 29.69% | -213.54% | N/A |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.53 | 1.84 |
Quick Ratio (TTM) | 1.53 | 2.10 |
D/E Ratio (TTM) | 0.11 | 0.54 |
Interest Coverage (TTM) | 8.61 | 10.64 |
Piotroski F-Score | 6 | 6 |
Altman Z-Score | 2.44 | 9.11 |
LTL to 5YR AVG FCF | N/A | 3.47 |
Shares Outstanding Growth 5YR AVG | N/A | 57.49% |